U.S. Department of Health & Human Services

COVID-19 Therapeutic Locator

Please use COVID-19 Treatments. Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations for Paxlovid (oral antiviral), Lagevrio (oral antiviral), and outpatient Veklury (intravenous antiviral infusion). COVID-19 therapeutics require a prescription to obtain. Maintained by the U.S. Department of Health & Human Services.

Example records
NamebrandCityaddressStateaddressZIP CodeaddressStreet AddressaddressCountyaddressNational Drug CodechemicalOrder LabelproductCourses AvailablequantityGeocoded AddressgeospatialNpiregistrationLast Report Datetemporal
Walmart Pharmacy #5123Colorado SpringsCO809205550 E Woodmen RdEl Paso00069-1101-20Renal Paxlovid6POINT (-104.725347 38.942711)133616831912/31/2023 12:00:00 AM
CVS Store #05939BurlingtonMA1803242 Cambridge StMiddlesex00069-1101-20Renal Paxlovid2POINT (-71.202035 42.513225)189197143801/22/2024 12:00:00 AM
WALGREENS STORE #06209StockbridgeGA302811855 HUDSON BRIDGE RDHenry00069-1101-20Renal Paxlovid8POINT (-84.24584 33.49964)181190489912/26/2023 12:00:00 AM
Use cases

Pharmacy Network Verification for Specialty Drug Distribution Contracts

A specialty pharmacy distributor evaluating retail pharmacy chains as potential partners cross-references NPI numbers and brand names against CMS enrollment records to confirm each location is a legitimate, active dispensing site before negotiating antiviral allocation agreements.

NpiNameAlternate NameProvider StatusStreet Address

Geographic Supply Gap Analysis for Telehealth Prescription Routing

A telehealth platform that prescribes COVID antivirals maps active dispensing locations against its patient population to identify counties or ZIP codes where patients cannot easily fill a prescription, informing decisions about which pharmacy partners to onboard.

Geocoded AddressZIP CodeCountyStateProvider Status

Fraud Screening for COVID Relief Program Billing Audits

A healthcare fraud analytics firm auditing government reimbursement claims for COVID therapeutics checks whether billing NPIs correspond to locations that were actually listed as active dispensing sites during the claim period, flagging providers that billed for drugs they were not authorized or equipped to dispense.

NpiProvider StatusLast Report DateNational Drug CodeStreet Address
Related datasets
COVID-19 TreatmentsU.S. Department of Health & Human ServicesCOVID-19 and Flu Outpatient Treatment LocatorCOVID-19 Test to TreatU.S. Department of Health & Human ServicesCOVID-19 Uninsured Provider ReimbursementsU.S. Department of Health & Human ServicesCOVID-19 Provider FAQ TemplateU.S. Department of Health & Human ServicesCOVID-19 Hospital Data Reporting TemplateU.S. Department of Health & Human ServicesDrug Manufacturer ContactsU.S. Department of Health & Human ServicesMedicare Physician & Other PractitionersU.S. Department of Health & Human ServicesInnovation Center AdvisorsU.S. Department of Health & Human ServicesProvider Relief Fund COVID-19 High-Impact PaymentsU.S. Department of Health & Human ServicesOpioid Treatment Program ProvidersU.S. Department of Health & Human ServicesMedicaid Drug Rebate Program State Contact InformationU.S. Department of Health & Human ServicesHospital Price Transparency Enforcement Activities and OutcomesU.S. Department of Health & Human ServicesAssisted Reproductive Technology Services and ProfilesU.S. Department of Health & Human ServicesHospital Change of OwnershipU.S. Department of Health & Human ServicesProvider Relief Fund, Accelerated, and Advance PaymentsU.S. Department of Health & Human ServicesRural Health Clinic All OwnersU.S. Department of Health & Human ServicesMedicare Inpatient HospitalsU.S. Department of Health & Human ServicesPerformance Year Financial and Quality ResultsU.S. Department of Health & Human ServicesProvider Relief Fund COVID-19 Nursing Home Quality Incentive ProgramU.S. Department of Health & Human Services